Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Rheinisch-Westfälische Technische Hochschule Aachen is active in the Biotechnology & Pharmaceuticals technology area. The portfolio currently contains 1 pending office action, which represents the total active volume for the institution's patent prosecution. This 1 pending office action indicates a focused effort to secure rights within this specific technical field.
The prosecution effort is distributed across 1 distinct art unit and involves 1 distinct examiner. This concentration suggests that the university's strategy in the Biotechnology & Pharmaceuticals field is currently focused on a specific technical niche. For a practitioner, the presence of 1 distinct examiner indicates a singular point of contact for all pending matters.
PHAN, DOAN THI-THUC is the busiest examiner, with a busiest examiner pending count of 1. This examiner is responsible for the active office action currently listed for the university. The focus on PHAN, DOAN THI-THUC as the primary examiner means that their specific tendencies will be the most significant factor in the institution's immediate prosecution outcomes.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHAN, DOAN THI-THUC | 1 | 42.8% | +47.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18014274 | POLYMERIC MICELLES COMPRISING GLUCURONIDE-PRODRUGS | PHAN, DOAN THI-THUC | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18014274 | POLYMERIC MICELLES COMPRISING GLUCURONIDE-PRODRUGS | PHAN, DOAN THI-THUC | 1613 | §103 | Non-Final OA | 4d overdue | Pending | Jan 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRheinisch-Westfälische Technische Hochschule Aachen has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Doan Thi-Thuc Phan has the most, with 1 of Rheinisch-Westfälische Technische Hochschule Aachen's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
